A股異動 | 傳化智聯(002010.SZ)回吐6.63% 否認徵信領域投資
格隆匯9月10日丨昨日漲停的傳化智聯(002010.SZ)今天回吐6.63%,報9.01元,總市值277億港元。傳化智聯今早發佈公吿稱,近日,公司關注到有媒體在網絡發佈了本公司將與其他多家企業合資設立徵信公司的信息。經核實,本公司不存在與其他多家企業合資設立徵信公司的情形,報道所提到的涉及本公司的信息均為不實信息。此前有媒體報道稱,螞蟻金服將與浙江旅遊投資集團、杭州金融投資集團、傳化智聯等合資成立個人信用評分公司,並稱該合資公司將接管螞蟻金服現有相關業務,其中螞蟻持股35%,浙旅投持股35%,傳化持股為7%左右。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.